↓ Skip to main content

Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, March 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia
Published in
Clinical Lymphoma, Myeloma & Leukemia, March 2019
DOI 10.1016/j.clml.2019.03.012
Pubmed ID
Authors

Jun Liu, Xu Tan, Ying-Ying Ma, Yao Liu, Li Gao, Lei Gao, PeiYang Kong, Xian-Gui Peng, Xi Zhang, Cheng Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 25%
Other 2 10%
Student > Master 2 10%
Student > Bachelor 1 5%
Student > Doctoral Student 1 5%
Other 0 0%
Unknown 9 45%
Readers by discipline Count As %
Medicine and Dentistry 6 30%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Nursing and Health Professions 1 5%
Mathematics 1 5%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 9 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2020.
All research outputs
#20,663,600
of 25,385,509 outputs
Outputs from Clinical Lymphoma, Myeloma & Leukemia
#1,545
of 2,059 outputs
Outputs of similar age
#280,493
of 363,975 outputs
Outputs of similar age from Clinical Lymphoma, Myeloma & Leukemia
#26
of 54 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,059 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.